Primary tabs

News

LSTM led partnership awarded £1.5 million for NTD drug development

From: LSTM

LSTM commits to pay the ‘UK settlement’ fee for its EU employees

From: LSTM

Liverpool School of Tropical Medicine (LSTM) appoints Professor David Lalloo as its new Director

From: LSTM

LSTM's A·WOL consortium celebrates 10-year milestone

From: LSTM

LSTM's 118th Annual General Meeting

From: LSTM

LF patients

New combination therapy of registered re-purposed drugs dramatically shortens anti-Wolbachia therapy for lymphatic filariasis and onchocerciasis from weeks to days

From: LSTM

AWOL identifies novel chemotypes in the search for drugs to combat LF and onchocerciasis

From: LSTM

LSTM’s ambassador for NTDs, Professor Tchuem Tchuenté, talks at BSP Autumn Symposium

From: LSTM

Professor Janet Hemingway announces her intention to retire as Director of LSTM

From: LSTM

Infected Abroad: Mosquito Bites

A·WOL Lab on Discovery Channel

LSTM at the Big Bang North West festival

From: LSTM

MRC Confidence in Concept 2017: Awards announced

From: LSTM

LSTM’s A·WOL Consortium at Africa Oyé

From: LSTM

LSTM Seminar report: "Antimicrobial Resistance; it’s in you!"

From: LSTM

LSTM launches new Transposon Registry

From: LSTM

Liverpool’s first Pint of Science festival

From: LSTM

LSTM faculties receive Athena SWAN Bronze Awards

From: LSTM

Our recent activities by LSTM people in the field of NTDs

From: LSTM

Cross section filarial nematode wolbachia in green

New anti-Wolbachia drug regimen could reduce treatment times of lymphatic filariasis and onchocerciasis to 1-2 weeks

From: LSTM

MRC Confidence in Concept Fund 2016-2017 Now open for applications

From: LSTM

The UK Coalition Against NTDs join forces to advance the agenda 5 Years On

From: LSTM

Fifth anniversary of the London Declaration on NTDs: Progress made and challenges remaining

From: LSTM

Centre of Excellence in Infectious Diseases Research launched

From: LSTM

Fig 2. Histological analysis of endobacteria content and worm age.

A·WOL compared various drugs for their efficacy against onchocerciasis in a randomized, open-label, pilot trial

New drug candidate for the curative treatment of onchocerciasis and lymphatic filariasis

From: LSTM

LSTM Seminar: Microbial symbionts for control of mosquito-borne disease.

From: LSTM

Seminar report: Neglected tropical diseases and LSTM

From: LSTM

Professor Janet Hemingway receives Honorary Doctor of Science from the University of Chester

From: LSTM

Liverpool unveils world-class Knowledge Quarter vision

From: LSTM

Liberia to launch COUNTDOWN programme to support interventions against Neglected Tropical Diseases

From: LSTM

Seminar Series report: Why research integrity (RI) isn’t just ‘somebody else’s problem’

From: LSTM

The Bangladesh Filariasis Elimination Programme visits LSTM

From: LSTM

Liverpool College visits LSTM

From: LSTM

A·WOL receives $3.5 million supplementary grant

From: LSTM

LSTM receives US$ 10 million in its fight against Neglected Tropical Diseases

From: LSTM